Future Fields is a biotechnology company that produces recombinant proteins at scale, focusing on difficult-to-express proteins and high-quality recombinant proteins.

Future Fields

Innoterra enables the agri-food ecosystem through digital connectivity, connecting Indian retailers and buyers with global farmers and sellers transparently and fairly. It offers tech-based solutions for various agricultural sectors, including dairy, food products, and bioscience.

Innoterra

GFI Europe is dedicated to promoting alternative proteins such as plant-based and cultivated meat. It engages in advocacy for policies and investment to make these options more accessible.

GFI Europe

Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngine™, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science. 

Future Fields is a proud business member of 1% for the Planet, a global organization that accelerates smart environmental giving. We are also a part of the United Nations Global Compact initiative, committing to aligning strategies and operations with universal principles on human rights, labor, environment and anti-corruption, and taking actions that advance societal goals.

Learn more about how we’re transforming science for the future at https://futurefields.io/.

Sustainable Development Technology Canada

Y Combinator

Bossanova Investimentos

Pioneer Fund

Coughdrop Capital

Bee Partners

Narrative Fund

GROW Agrifoodtech Accelerator

Siddhi Capital

Toyota Ventures

Amplify Capital

Builders VC

Climate Capital

AgFunder

Green Circle Foodtech Ventures

Milad Alucozai

Inter-leukin' good! 👀📸 

We’re jazzed about our #interleukin going out the door yesterday. #IL2 is the beginning of more exciting launches to come. 🙌

View our IL-2 here 👉 https://bit.ly/4d6r9tV

YEG Deeptech Summer Shindig was for the books 😎☀️

We beat the heat last week with some pretty cool lab tours, ice cream making, and swapping stories of building a deeptech startup in Edmonton. 🚀

Thanks for inviting us out, G2V Optics Inc., Zero Point Cryogenics!

#YEG #deeptech #yegtech #yegstartup

Great to receive growth factors from our friends at Future Fields as part of our automated biomanufacturing Canada-Innovate UK grant.   It has never made sense to us that growth factors are added to cell culture, sporadically, in large excess.  I mean, we understand why.  Humans don't tend to want to do media changes at 2 am.  But science, in the case of cells, really does not sleep.  However, neither do Emmet and Marty.  Who can helpfully perform temperature-controlled media/growth factor exchanges automatically whenever you want.  Helping scientists get some well-needed rest, designing better experiments, mirroring more closely physiologically operating biological systems, and then seamlessly scaling straight to production too.  Check out our web pages if you want to know more.  Plus, we like a good bit of merch, particularly pin badges 😀.

#stemcells #biomanufacturing #automation #researchanddevelopment

Product compliance goes beyond the lab - we ensure our products are in line with government regulations. Our regulatory experts are here to answer any questions you may have! 🙌

Learn more about quality at Future Fields 👉: https://bit.ly/4dG9zxu

Every lab talks about reliability -  but what does it actually look like? 🥼🔍

Our QC team conducts in-process testing at critical control points to ensure batch-to-batch consistency. 🔁

Finished product testing involves various analytical techniques, which are detailed on each Product Data Sheet.

Learn more about quality at Future Fields 👉 https://bit.ly/4fA0xUk

"How do I reconstitute my lyophilized recombinant protein?"

This is a common question we get from our customers. Paige, Senior Research Scientist from our Protein Biochemistry team walks us through the reconstitution process. 👩🔬

Watch below 👇

Exciting new research from Sorbonne Université shows IL-2 has potential therapeutic potential for multiple sclerosis! 🙌

Multiple sclerosis is an autoimmune disease that attacks nerve myelin of the brain and spine. 🧠 Studies found that providing low doses of IL-2 activated regulatory T cells reduced the activity of multiple sclerosis disease.

Read the publication:
https://bit.ly/4dxsxGj

#IL2 #Tregs #multiplesclerosis

Quality is upheld by every Future Fielder, but we can thank our Quality Assurance (QA) team for keeping us in check. ✅

QA leads our document management system and oversees manufacturing activities to ensure consistent product quality. 🙌

Learn more about quality at Future Fields 👉 https://bit.ly/46jvb01

Lots of fun finds from our ABC Swap last week! 👕🔁

Our Sustainability Committee hosted a team ABC (Appliances 📻, Boredom Busters 📚, Clothing 👗) Swap event to promote a circular economy and eco-friendly values in an engaging way.

We exchanged useful gadgets and toys, picked up new books, and gave new life to formerly loved garments—any remaining items are being saved for donation.

Shoutout to the Sustainability Committee for bringing us together in a meaningful way. Here's to more sustainable initiatives and fun in the future! ♻️

In case you missed it - we launched a new protein last week. 👀🩵

Part of the IL (Interleukin) Superfamily 🦸, IL-2 plays a significant role in growing T cells. 

Bioactive, high in purity, and excelling in safety, what makes this recombinant #IL2 unique is that it's made by transgenic fruit flies 🪰 in our Green-certified lab. 🥼

Request a free sample for your research 👇 https://bit.ly/4bQKBKe

Metric
Company Name	Future Fields	Innoterra	GFI Europe
Symbol
MSH ID	IO:FUTUREFIELDS	COM:INNOTERRA	ORG:GFIEUROPE
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Consumer Services	Consumer Services
Industry	Biotechnology	Agri-tech	Food and Agriculture
Country	CA	IN	BE
Stage
Employee Count
Website	futurefields.io	innoterra.com	gfieurope.org
LinkedIn	future-fields	innoterra	gfi-europe
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

IO:FUTUREFIELDS

Future Fields

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue